Orasure Technologies, Inc. · NASDAQ:OSUR

Orasure Technologies — Q1 2026 Earnings Presentation

10 slides from Orasure Technologies's earnings presentation, May 6, 2026

  1. Slide 1: OraSure Investor Update May 2026

    OraSure Investor Update May 2026 EXHIBIT 99.2

  2. Slide 2: Disclaimers: Forward-Looking Statements

    © 2026 OraSure Technologies, Inc. 2OTI Proprietary Disclaimers Forward-Looking Statements: This presentation of OraSure Technologies, Inc. (the “Company” or “OraSure”) contains certain “forward-looking statements” within the meaning of federal securities laws, including with respect to products, pro

  3. Slide 3: Disciplined execution driving stronger platform for growth

    © 2026 OraSure Technologies, Inc. 3OTI Proprietary Disciplined execution driving stronger platform for growth 3+ years of progress in transformation strategy Strengthen our Foundation Elevate our Core Growth Accelerate our Profitable Growth Cost productivity • One OTI: combined 2 business units into

  4. Slide 4: Financial performance summary

    © 2026 OraSure Technologies, Inc. 4OTI Proprietary Financial performance summary Innovating and operating with disciplined execution and accountability Q1 results • Total Revenue: $27.9 million • +4% q/q growth • Non-GAAP Gross Margin: 43.4% External environment: We are seeing stable demand in key s

  5. Slide 5: Clear strategy to innovate and accelerate growth with near-term catalysts

    © 2026 OraSure Technologies, Inc. 5OTI Proprietary Clear strategy to innovate and accelerate growth … with near-term catalysts in attractive markets Delivering our near-term product roadmap Plan to launch differentiated innovation by executing on near-term milestones … aligned with long-term healthc

  6. Slide 6: Product roadmap: anticipated near-term milestones

    © 2026 OraSure Technologies, Inc. 6OTI Proprietary Product roadmap: anticipated near-term milestones Description Protein-specific blood collection & sample stabilization At-home first-void urine self-collection Disposable molecular dx, rapid test Blood self-collection; Dot = dried blood spot vs. cap

  7. Slide 7: Expanding our pipeline in high-value growth markets

    © 2026 OraSure Technologies, Inc. 7OTI Proprietary Expanding our pipeline in high-value growth markets Illustrative examples leveraging OTI strengths Notes: •Example criteria are not all inclusive •Matrix excludes less attractive opportunities Example criteria: Market size Growth rate Profitability

  8. Slide 8: OraSure today: stronger, focused, and executing for sustainable growth

    © 2026 OraSure Technologies, Inc. 8OTI Proprietary OraSure today: stronger, focused, and executing for sustainable growth Strengthen our Foundation Elevate our Core Growth Accelerate our Profitable Growth

  9. Slide 9: Appendix

    © 2026 OraSure Technologies, Inc. 9OTI Proprietary Appendix

  10. Slide 10: Reconciliation of Non-GAAP Gross Margin

    © 2026 OraSure Technologies, Inc. 10OTI Proprietary Reconciliation of Non-GAAP Gross Margin OraSure Technologies GAAP to Non-GAAP Reconciliation ($ in 000's)

Orasure Technologies — Q1 2026 Earnings Presentation on 6ix